Clinical risks include nausea, vomiting, raised heart rate, and potential hypoglycaemia if used alongside diabetes medications, all without any medical supervision or quality assurance
Physiol Rev 87(4):14091439 Campbell JE, Drucker DJ (2013) Pharmacology, physiology, and mechanisms of incretin hormone action
Additionally, if you take your dose and notice a sudden, complete lack of appetite suppression compared to previous weeks, the medication may have lost its potency due to heat exposure
Using density functional theory calculations, the catalytic cycle of the ruthenium catalyst was predicted
Outcomes Our primary outcome was a composite outcome encompassing five major clinical events: all-cause hospitalization, all-cause mortality, major adverse cardiovascular events (MACEs), major adverse kidney events (MAKEs), major adverse liver outcomes (MALO), and hepatocellular carcinoma (HCC)